Oric Pharmaceuticals

ORICNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.399 B

$13.50 +4.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$129.5M

Loss-making

Shares outstanding

103,652,656

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#140InnovivaINVA$1.48B
#141ArriVent BioPharmaAVBP$1.44B
#142Oric PharmaceuticalsORIC$1.40B
#143Phibro Animal HealthPAHC$1.39B
#144Lb PharmaceuticalsLBRX$1.38B

Where these numbers come from

Share counts and financials for Oric Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.